Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic Cancer
Wungki Park, Akhil Chawla, Eileen M. O’Reilly
JAMA (2021) Vol. 326, Iss. 9, pp. 851-851
Open Access | Times Cited: 1126

Showing 26-50 of 1126 citing articles:

Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer
Guillaume Fonteneau, Alexandra Redding, Hannah Hoag-Lee, et al.
Cancer Discovery (2022) Vol. 12, Iss. 8, pp. 1984-2005
Open Access | Times Cited: 44
Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model
Hao Chi, Haiqing Chen, Rui Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 40
KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer
Yuming Luo, Zhihua Li, Yao Kong, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 39
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
Sakti Chakrabarti, Leslie Bucheit, Jason S. Starr, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004485-e004485
Open Access | Times Cited: 39
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Derk C.F. Klatte, Bas Boekestijn, Anke M. Onnekink, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1223-1231.e4
Open Access | Times Cited: 38
Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers
Huan Zhang, Kailei Cao, Jingrong Xiang, et al.
Cancer Letters (2023) Vol. 571, pp. 216345-216345
Closed Access | Times Cited: 38
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
Tommaso Schepis, Sara Sofia De Lucia, Antonio Pellegrino, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3423-3423
Open Access | Times Cited: 36
TransformEHR: transformer-based encoder-decoder generative model to enhance prediction of disease outcomes using electronic health records
Zhichao Yang, Avijit Mitra, Weisong Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy
Xiaoyu Liu, Yaping Zhuang, Wei Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer
Daoyan Wei, Liang Wang, Xiangsheng Zuo, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 655-662
Open Access | Times Cited: 35
Advances and Prospects in the Treatment of Pancreatic Cancer
Huaiyu Duan, li li, Shiming He
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3973-3988
Open Access | Times Cited: 32
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma
Yao Kong, Yuming Luo, Shangyou Zheng, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3077-3094
Open Access | Times Cited: 27
Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer
Wenjie Shi, Thomas Wartmann, Sara Accuffi, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 125-134
Open Access | Times Cited: 26
Claudin and pancreatic cancer
Chen Wang, Na Wu, Beibei Pei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 25
Recent Advances in Nanoparticle-Mediated Co-Delivery System: A Promising Strategy in Medical and Agricultural Field
Mingshan Li, Xiaowei Sun, Meizhen Yin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5121-5121
Open Access | Times Cited: 25
Immune profiling and prognostic model of pancreatic cancer using quantitative pathology and single-cell RNA sequencing
Kai Chen, Qi Wang, Xinxin Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2923-2923
Open Access | Times Cited: 24
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer
Ana Babić, Michael H. Rosenthal, Tilak Sundaresan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Multifaceted role for p53 in pancreatic cancer suppression
Stephano S. Mello, Brittany M. Flowers, Paweł K. Mazur, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 10
Open Access | Times Cited: 23
Causal associations between modifiable risk factors and pancreatitis: A comprehensive Mendelian randomization study
Xiao‐Tong Mao, Sheng-Han Mao, Hongxin Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer
Daniele Campa, Manuel Gentiluomo, Angelika Stein, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 104020-104020
Open Access | Times Cited: 23
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 22
Next-generation therapies for pancreatic cancer
Conor Buckley, Eileen M. O’Reilly
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 1-3, pp. 55-72
Open Access | Times Cited: 14
Exploiting pancreatic cancer metabolism: challenges and opportunities
Maria Chiara De Santis, Bruno Bockorny, Emilio Hirsch, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 592-604
Open Access | Times Cited: 14

Scroll to top